Methods and systems for producing recombinant viral antigens
US6692751B1 · kind B1 · utility
5Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 16, 1997 |
| Grant date | Feb 17, 2004 |
| Priority date | — |
| Expiry date | Sep 16, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens., diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.